ArchiMed’s $1.2bn private equity deal with Natus Medical was the Medical devices industry’s biggest cross border deal of Q2 2022 as cross border deals worth $6.9bn were announced globally in the quarter, according to GlobalData’s deals database.
The value marked an increase of 1.9% over the previous quarter and a drop of 44.7% when compared with the last four-quarter average of $12.52bn.
In terms of number of cross border deals, the sector saw a drop of 16.28% with 153 deals in Q2 2022 against the average of 182.75 deals in the last four-quarters.
In value terms, Europe led the activity with cross border deals worth $3.5bn.
